tiprankstipranks
Trending News
More News >
Lotus Bio-Technology Development Corp. (LBTD)
OTHER OTC:LBTD
US Market

Lotus Bio-Technology Development (LBTD) Income Statement

Compare
8 Followers

Lotus Bio-Technology Development Income Statement

Last quarter (Q3 2018), Lotus Bio-Technology Development's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lotus Bio-Technology Development's net income was $-12.98K. See Lotus Bio-Technology Development’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Depreciation and Amortization
$ 167.90K$ 228.49K$ 236.56K$ 206.30K$ 171.86K
EBITDA
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Pretax Income
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Income
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
334.41M 334.41M 334.41M 334.41M 334.41M
Weighted Average Shares Outstanding (Diluted)
334.41M 334.41M 334.41M 334.41M 334.41M
Currency in USD

Lotus Bio-Technology Development Earnings and Revenue History